project id: TCGA-COAD; case submitter id: TCGA-A6-6649; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; state: released; normal tumor genotype snp match: Yes; spectrophotometer method: UV Spec; age at index: 66; days to birth: -24237; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1944; age at diagnosis: 24237; ajcc pathologic m: M0; ajcc pathologic n: N1b; ajcc pathologic stage: Stage IIIB; ajcc pathologic t: T3; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 735.0; icd 10 code: C18.2; last known disease status: not reported; morphology: 8140/3; primary diagnosis: Adenocarcinoma, NOS; prior malignancy: yes; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Ascending colon; synchronous malignancy: Not Reported; tissue or organ of origin: Ascending colon; tumor grade: Not Reported; year of diagnosis: 2010; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to sample procurement: 0; intermediate dimension: 0.8; longest dimension: 1.3; oct embedded: No; shortest dimension: 0.6; portion submitter id: TCGA-A6-6649-01A-11; percent lymphocyte infiltration: 7.0; percent necrosis: 10.0; percent neutrophil infiltration: 7.0; percent normal cells: 10.0; percent stromal cells: 0.0; percent tumor cells: 80.0;